Combined subthalamic and nucleus basalis of Meynert deep brain stimulation for Parkinson’s disease with dementia (DEMPARK-DBS): protocol of a randomized, sham-controlled trial

INTRODUCTION: Dementia in Parkinson’s disease (PDD) is a common non-motor symptom of advanced disease, associated with pronounced neocortical cholinergic deficits due to neurodegeneration of the nucleus basalis of Meynert (NBM) and its cholinergic terminals. In advanced PD, patients often require ad...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Res Pract
Autors principals: Daniels, Christine, Steigerwald, Frank, Capetian, Philipp, Matthies, Cordula, Malzahn, Uwe, Heuschmann, Peter U., Volkmann, Jens
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Clinical Trial Protocol
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650115/
https://ncbi.nlm.nih.gov/pubmed/33324941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s42466-020-00086-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars